C07D 285/02
Thiadiazoles
Official title: Thiadiazoles; Hydrogenated thiadiazoles
C07D285/02 (Thiadiazoles) appears on 2,266 US grants and 1,505 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,266
- Published applications
- 1,505
- Assignees
- 854
- Inventors
- 5,900
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 43 | 0 |
| 1977 | 56 | 0 |
| 1978 | 61 | 0 |
| 1979 | 47 | 0 |
| 1980 | 44 | 0 |
| 1981 | 66 | 0 |
| 1982 | 40 | 0 |
| 1983 | 42 | 0 |
| 1984 | 45 | 0 |
| 1985 | 47 | 0 |
| 1986 | 45 | 0 |
| 1987 | 45 | 0 |
| 1988 | 39 | 0 |
| 1989 | 31 | 0 |
| 1990 | 49 | 0 |
| 1991 | 42 | 0 |
| 1992 | 42 | 0 |
| 1993 | 53 | 0 |
| 1994 | 39 | 0 |
| 1995 | 38 | 0 |
| 1996 | 43 | 0 |
| 1997 | 42 | 0 |
| 1998 | 47 | 0 |
| 1999 | 50 | 0 |
| 2000 | 41 | 0 |
| 2001 | 65 | 10 |
| 2002 | 46 | 46 |
| 2003 | 39 | 53 |
| 2004 | 28 | 78 |
| 2005 | 22 | 75 |
| 2006 | 44 | 77 |
| 2007 | 49 | 67 |
| 2008 | 37 | 91 |
| 2009 | 45 | 67 |
| 2010 | 63 | 117 |
| 2011 | 54 | 71 |
| 2012 | 81 | 70 |
| 2013 | 67 | 67 |
| 2014 | 76 | 84 |
| 2015 | 57 | 58 |
| 2016 | 62 | 56 |
| 2017 | 42 | 63 |
| 2018 | 45 | 56 |
| 2019 | 49 | 39 |
| 2020 | 35 | 51 |
| 2021 | 30 | 43 |
| 2022 | 24 | 33 |
| 2023 | 16 | 35 |
| 2024 | 19 | 48 |
| 2025 | 24 | 27 |
| 2026 | 10 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders2 Jun 2026US 12,643,918 B2Betagenon AB
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Compound, display panel and display device26 May 2026US 12,641,998 B2Wuhan Tianma Microelectronics Co., Ltd.
- 2,5-dimercapto-1,3,4-thiadiazole (DMTD) zinc salt derivatives28 Apr 2026US 12,614,716 B2Ohio State Innovation Foundation
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Bioactive Conjugate, Preparation Method Therefor and Use Thereof17 Sep 2026US 2026/0273080 A2BeOne Medicines I GmbH
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
- N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels background6 Aug 2026US 2026/0226040 A1Merck Sharp & Dohme Corp.
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
Most cited
By later US patents
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient141US 4,914,097 AMitsubishi Kasei Corporation · 1990
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009